Lungene

Blodpropp i lungene (lungeemboli)

Blodproppsykdom

Pasientinformasjon

Hjerte/kar

Kliniske kapitler

Håndboken

Norsk Elektronisk Legehåndbok

Hva er blodpropp i lungene (lungeemboli)?

Årsak

Diagnostikk

Behandling

Medikamentell behandling

Forebyggende behandling

Prognose

Vil du vite mer?

Lungeemboli

--&gt; http://dx.doi.org/10.1093/eurheartj/ehz405

Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J 2019. doi:10.1093/eurheartj/ehz405 

--&gt; https://tidsskriftet.no/2001/02/klinikk-og-forskning/kirurgi-ved-kronisk-lungeemboli

Baksaas ST, Geiran OR, Iversen S. Kirurgi ved kronisk lungeemboli. Tidsskr Nor Lægeforen 2001; 121: 431-3. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=26780736[uid]

Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism. J Thromb Thrombolysis 2016; 41: 3-14. pmid:26780736 

Douketis J, Tosetto A, Marucci M, et al. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 2011; 342: d813. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=28093420[uid]

Apenteng PN, Hobbs FR, Roalfe A, et al. Incidence of venous thromboembolism in care homes: a prospective cohort study. Br J Gen Pract 2017 Feb; 67 (655): e130-e137. pmid:28093420 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=26845754[uid]

Di Minno MN, Ambrosino P, Ambrosino F, et al. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superﬁcial vein thrombosis: a systematic review and meta-analysis. J Thromb Haemost. 2016; 14: 964-72. pmid:26845754 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=26847621[uid]

Huang W, Goldberg RJ, Anderson FA, et al . Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study. J Thromb Thrombolysis 2016. pmid:26847621 

--&gt; https://www.legeforeningen.no/contentassets/1f202f6c716b43769dcb4f1674d4c701/hjerteforum-3-2016-4-kronisk-tromboembolisk-pulmonal-hypertensjon.pdf

Andreassen AK. Kronisk tromboembolisk pulmonal hypertensjon. Hjerteforum 2016; 29 (nr. 3): 19-25. 

Hughes MJ, Stein PD, Matta F. Silent pulmonary embolism in patients with distal deep venous thrombosis: systematic review. Thromb Res. 2014 Dec;134(6):1182-5. doi: 10.1016/j.thromres.2014.09.036 

Velmahos GC, Spaniola K, Tabbara M, et al. Pulmonary embolism and deep venous thrombosis in trauma: are they related?. Arch Surg 2009; 144: 928-32. 

Stanley A and Young A. Primary prevention of thromboembolism in medical and surgical oncology patients. BJC 2010; 102; S10-16. 

Goldhaber SZ.Risk factors for venous thromboembolism. J Am Coll Cardiol 2010; 56: 1-7. 

Eichinger S, Weltermann A, Minar E, et al. Symptomatic pulmonary embolism and the risk of recurrent venous thromboembolism. Arch Intern Med 2004; 164: 92-6. 

Carrier M, Le Gal G, Wells PS, Fergusson D, Ramsay T, Rodger MA. Systematic review: The Trousseau Syndrome revisited: Should we screen extensively for cancer in patients with venous thromboembolism? Ann Intern Med 2008;149: 323-33. 

Trigg DE, Wood MG, Koides PA et al. Hormonal Influences on Haemostasis in Women. Sem Thromb Haemost 2011; 37: 77-86. 

Reid R, Leyland N, Wolfman W et al.Oral Contraceptives and the Risk of venous thromboembolism: An Update. J Obstet Gynaecol Can 2010; 32: 1192-7. 

Olie V, canonico M, Scarabin P-Y. Postmenopausal hormone therapy and venous thromboembolism. Thrombosis Res 2011 (E-Pub ahead of print). 

Canonico M, Plu-Bureau G, Lowe GDO, Scarabin P-Y. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis . BMJ 2008; 336: 1227-31. 

Deneux-Tharaux C, saucedo M, Bouvier-Colle MH. Pulmonary embolism in pregnancy. The Lancet 2010; 375: 1778-9. 

Hervig T, Haram K, Sandset PM. Dyp venetrombose hos gravide. Tidsskr Nor Lægeforen 1998; 118: 4093-7. 

Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63. 

Gavish I, Brenner B. Air travel and the risk of thromboembolism. Intern Emerg Med 2010 Nov 6. Epub ahead of print. 

Watson HG and Baglin TP. Guidelines on travel-related venous thrombosis. BJH 2011; 152: 31-34. 

Wells PS. Integrated strategies for the diagnosis of venous thromboembolism. J Thromb Haemost 2007; 5 (suppl. 1): 41-50. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=24643601[uid]

Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 2014; 311: 1117-24. pmid:24643601 

Gibson NS, Sohne M, Kruip MJ, et al. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism. Thromb Haemost 2008; 99: 229-34. 

Hendriksen JMT, Geersin G-J, Lucassen WAM, et al. Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care. BMJ 2015; 351: h4438. doi:10.1136/bmj.h4438 

Geersing G-J, Erkens PMG, Lucassen WAM, et al. Safe exclusion of pulmonary embolism using the Wells rule and qualitative D-dimer testing in primary care: prospective cohort study. BMJ 2012; 345: e6564. 

ATS Guideline – Evaluation of Suspected Pulmonary Embolism in Pregnancy. Radiology 2012; 262 (2): 635-646 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=22417276[uid]

Krishnan AS, Barrett T. Images in clinical medicine. Westermark sign in pulmonary embolism. N Engl J Med 2012; 366: e16. pmid:22417276 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=30057872[uid]

Moore AJE, Wachsmann J, Chamarthy MR, et al. Imaging of acute pulmonary embolism: an update. Cardiovasc Diagn Ther 2018; 8: 225-43. pmid:30057872 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=21301781[uid]

Pesavento R, de Conti G, Minotto I, et al; for the TACEP study.The value of 64-detector row computed tomography for the exclusion of pulmonary embolism. Thromb Haemost. 2011; 105. 901-7. PMID: 21301781 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=31410539[uid]

Bajc M, Schümichen C, Grüning T, et al. EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond. Eur J Nucl Med Mol Imaging 2019. pmid:31410539 

Shahir K, Goodman LR, Tali A, Thorsen KM, Hellman RS. Pulmonary embolism in pregnancy: CT pulmonary angiography versus perfusion scanning. Am J Roentgenol. 2010; 195 (3): W214-20 

--&gt; http://dx.doi.org/10.4045/tidsskr.13.0310

Semb VB, Tveit A. Begrenset malignitetsutredning ved idiopatisk venøs trombose. Tidsskr Nor Legeforen 2014; 134: 407-11. doi:10.4045/tidsskr.13.0310 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=28851126[uid]

Delluc A, Antic D, Lecumberri R, et al. Occult cancer screening in patients with venousthromboembolism: guidance from the SSC of the ISTH. J Thromb Haemost. 2017; 15: 2076-9. pmid:28851126 

Reikvam Å og Sandset PM. Warfarinbehandling i praksis – Tryggere antikoagulasjon. Skriftserie for leger 2010 (ISBN-13 978-82-8070-083-4). 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=33007077[uid]

Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 2020; 4: 4693-4738. pmid:33007077 

Venetz C, Jiménez D, Mean M, Aujesky D. A comparison of the original and simplified Pulmonary Embolism Severity Index. Thromb Haemost. 2011;106:423-8. doi: 10.1160/TH11-04-0263 

--&gt; https://app.magicapp.org/#/guideline/jOpV9L

Vandvik P (red.) Retningslinjer for antitrombotisk behandling og profylakse - 2020. Norsk Selskap for Trombose og Hemostase. v2.0. Publisert 27.05.2020. Siden lest 25.11.2020 

Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO; American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e691S-736S 

Rodina MT, Pendleton R, Wheeler M, Rodgers GM. The treatment of venous thromboembolism in special populations Thrombosis Research 2007; 119: 391-402. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=31630479[uid]

McBane 2nd RD, Wysokinski WE, Le-Rademacher JG, et al. Apixaban and dalteparin in active malignancy-associated venous thromboembolism. The ADAM VTE Trial. J Thromb Haemostat 2020; 18: 411-421. PMID: 31630479 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=26780744[uid]

Stevens SM, Woller SC, Bauer KA, et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis 2016; 41: 154-64. pmid:26780744 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=37336568[uid]

Planer D, Yanko S, Matok I, et al. Catheter-directed thrombolysis compared with systemic thrombolysis and anticoagulation in patients with intermediate- or high-risk pulmonary embolism: Systematic review and network meta-analysis. CMAJ 2023; 195: E833-E843. PMID: 37336568 

Simes J, Becattini C, Agnelli G, et al. Aspirin for the Prevention of Recurrent Venous Thromboembolism: The INSPIRE Collaboration. Circulation. 2014 Sep 23;130(13):1062-71 

Carrier M, Le Gal G, Wells PS et al. Systematic review: case-fatality rates of recurrent Venous Thromboembolism and major Bleeding Events Among Patients treated for venous Thromboembolism. Ann Intern Med 2010; 152: 578-89. 

Spyropoulus AC. To bridge or not to bridge: that’s the question. The argument FOR bridging therapy in patients on oral anticoagulants requiring temporary interruption for elective procedures. J Thromb Thrombolysis 2010; 29: 192-8. 

--&gt; http://dx.doi.org/10.1182/blood-2015-08-665927

Martinelli I, Lensing AW, Middeldorp S, et al. Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use. Blood 2016; 127: 1417-25. doi:10.1182/blood-2015-08-665927 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=29655808[uid]

Roncon L, Zuin M, Casazza F, et al. Impact of syncope and pre-syncope on short-term mortality in patients with acute pulmonary embolism. Eur J Intern 2018. pmid:29655808 

--&gt; https://indremedisineren.no/2019/01/post-lungeemboli-syndrom-en-ny-sykdomsbetegnelse/

Jervan Ø, Ghanima W. "Post lungeemboli syndrom" -en ny sykdomsbetegnelse?. Indremedisineren 2018. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=33407792[uid]

Haukeland-Parker S, Jervan Ø, Johannessen HH, Gleditsch J, Stavem K, Steine K et al. Pulmonary rehabilitation to improve physical capacity, dyspnea, and quality of life following pulmonary embolism (the PeRehab study): study protocol for a two-center randomized controlled trial. Trials. 2021 Jan 6;22(1):22. PMID: 33407792 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=26178041[uid]

Shen J-H, Chen H-L, Chen J-R, et al. Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis. J Thromb Thrombolysis 2016; 41: 482-92. pmid:26178041 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=J Thromb Haemost [ta]+AND+8[vol]+AND+957[page]

Ceriani E, Combescure C, Le Gal G et al. Clinical prediction rules for pulmonary embolism: a systematic review and metaanalysis. J Thromb Haemost 2010; 8: 957-70. 

The Task Force for the diagnosis and management of acute pulmonary embolism of the Eur Soc Card Guidelines on the diagnosis and management of acute pulmonary embolism (ESC). 2008; 29: 2276-2315. 

Bounemeaux H, Perrier A and Righini M. Diagnosis of venous thromboembolism: un update. Vasc Med 2010; 15: 399-406. 

Wells PS, Forgie MA, Rodger MA. Treatment of venous thromboembolism. JAMA 2014; 311:717-28. doi: 10.1001/jama.2014.65. 

Kearon C, Akl EA. Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism. Blood 2014; 123 (12): 1794-1801. doi: 10.1182/blood-2013-12-512681 

Segal JB, Streiff MB, Hofmann LV, Thornton K, Bass EB. Management of venous thromboembolism: a systematic review for a practice guideline. Ann Intern Med 2007; 146: 211-22. 

Blondon M, Bounemeaux H, Righini M et al.Treatment strategies for acute pulmonary embolism. Expert Opin Pharmacother 2009; 10: 1159-71. 

Colemen R and MacCallum P. Treatment and secondary prevention of venous thromboembolism in cancer. Br J C 2010; 102: Suppl 1: S17-23. 

Eichinger S and Kyrle PA. J. Duration of anticoagulation after initial idiopathic venous thrombosis – the swinging pendulum: Risk assessment to predict recurrence. Thromb Haemost 2009; 7: (suppl 1): 291-5. 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=26867832[uid]

Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report. Chest 2016; 149: 315-52. pmid:26867832 

Helsedirektoratet. Statens legemiddelverk. Informasjon om warfarin og de nye perorale antikoagulasjonsmidlene dabigatran, rivaroksaban og apixaban. IS-2050. Versjon 2.0. November 2013 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=32223112[uid]

Agnelli G, Becattini C, Meyer G, et al. Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer. N Engl J Med. 2020 Apr 23;382(17):1599-1607. PMID: 32223112 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=34204957[uid]

Dahm AEA. Cancer and Thrombosis: New Treatments, New Challenges. Med Sci (Basel) 2021; 9: 41. pmid:34204957 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=32919178[uid]

Hannevik T-L, Brekke J, Enden T, et al. Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism. Thromb Res 2020; 196: 238-244. pmid:32919178 

Geerts WH, Bergqvist D, Pineo GF et al. Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: S381-S453. 

Huo MH and Spyropoulis AC. The eighth American college of chest phycisians guidelines on venous thromboembolism prevention: implications for hospital prophylaxis strategies. J Thromb Thrombolysis 2010 (e-pub ahead of print). 

Ræder J og Nordentoft J. Dagkirurgi og anestesi. Tidsskr Nor Legeforen 2010; 130: 742-6. 

Amorosi SL, Tsilimingras K, Thompson D, Fanikos John, Weinstein MC, Goldhaber SZ. Cost analysis of "Bridging Therapy" with Low-Molecular-Weight Heparin versus Unfractionated Heparin during temporary interruption of chronic anticoagulation. A J Cardiol 2004; 93: 509-11. 

Klok FA and Huisman MV. Epidemiology and management of chronic thromboembolic pulmonary hypertension. Neth J Med 2010; 68: 347-351. 

--&gt; http://dx.doi.org/10.4045/tidsskr.17.0190

Rutherford O-CW, König MSS, Risnes K. Antidotbehandling ved bruk av direktevirkende antikoagulasjonsmidler. Tidsskr Nor Legeforen 2018. doi:10.4045/tidsskr.17.0190 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=26705385[uid]

Niessner A, Tamargo J, Morais J et al. Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis. Eur Heart J 2017; 38: 1710 - 6. PMID: 26705385 

Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d`Embolie Pulmonaire par Interruption Cave) randomized study. Circulation 2005; 112: 416-22. 

Sandset PM, Vandvik P (red.) Retningslinjer for antitrombotisk behandling og profylakse (2013, under oppdatering. Norsk Selskap for Trombose og Hemostase 2016. v1.2 published 10/12/16. Siden besøkt 12.03.2018 

--&gt; http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Search&amp;db=PubMed&amp;term=30535318[uid]

Bikdeli B, Wang Y, Jimenez D, et al. Association of Inferior Vena Cava Filter Use With Mortality Rates in Older Adults With Acute Pulmonary Embolism. JAMA Intern Med 2018. pmid:30535318 